Patents by Inventor Howard B. Lieberman

Howard B. Lieberman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RAD9 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC TOOL FOR PROSTATE CANCER
    Publication number: 20120028260
    Abstract: This disclosure provides a method of treating a human subject having a cancer which comprises administering to the subject a nucleic acid so as to inhibit expression of human RAD9 protein in a cell of the cancer so as to thereby treat the human subject. This disclosure also provides methods of assessing gains in prostate cancer therapy and detecting prostate cancer.
    Type: Application
    Filed: August 29, 2011
    Publication date: February 2, 2012
    Inventors: Howard B. Lieberman, Aiping Zhu
  • RAD 9 AS A DIAGNOSTIC,PROGNOSTIC,AND THERAPEUTIC TOOL FOR PROSTATE CANCER
    Publication number: 20100168202
    Abstract: This disclosure provides a method of treating a human subject having a cancer which comprises administering to the subject a nucleic acid so as to inhibit expression of human RAD9 protein in a cell of the cancer so as to thereby treat the human subject. This disclosure also provides methods of assessing gains in prostate cancer therapy and detecting prostate cancer.
    Type: Application
    Filed: June 6, 2008
    Publication date: July 1, 2010
    Inventors: Howard B. Lieberman, Aiping Zhu
  • Human radioresistance/cell cycle progression gene
    Patent number: 5882862
    Abstract: This invention provides isolated nucleic acids which encode a wildtype and a mutant human homolog of RAD9. This invention also provides purified and mutant wildtype human homologs of RAD9. This invention also provides methods for determining whether a subject has radiosensitivity; for predicting the effect of radiation therapy or chemotherapy on a subject; for detecting whether a subject has a predisposition to cancer; for treating a subject who is radiosensitive and for preventing or treating cancer in a subject who is radiosensitive.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: March 16, 1999
    Assignees: The Trustees of Columbia University in the City of New York, The Ontario Cancer Treatment and Research Foundation
    Inventors: Scott K. Davey, Howard B. Lieberman, Kevin M. Hopkins